This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Judge trims state claims from Lidoderm pay-for-delay suit

( May 5, 2015, 19:57 GMT | Official Statement) -- MLex Summary: US District Judge William H. Orrick partially granted a motion by Endo Pharmaceuticals, Teikoku Seiyaku, and Watson Pharmaceuticals to dismiss certain state claims in a case accusing them of unlawfully delaying the market entry of generic Lidoderm. Orrick agreed to dismiss consumer protection claims from end-payor plaintiffs Utah and Massachusetts. Orrick also dismissed the Government Employees Health Organization’s Rhode Island antitrust claim, consumer protection claims in 14 states and unjust enrichment claims in 28 states. See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections